Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A three-year clinical trial led by University of ...
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention ...
WEDNESDAY, March 30, 2016 -- More evidence linking the diabetes drug Actos to an increased risk of bladder cancer has surfaced in a new study that also finds the risk rises with increased use. Actos ...
The FDA has released an updated safety announcement following a fresh review of data on the type 2 diabetes treatment pioglitazon to confirm that the drug may increase a person’s likelihood of ...
Since studies of the diabetes drug Actos suggest an increased risk of bladder cancer for patients taking it for more than a year, Health Canada is reviewing the drug. The drug pioglitazone is sold ...
Please provide your email address to receive an email when new articles are posted on . Patients taking pioglitazone for type 2 diabetes demonstrated an increased risk for bladder cancer, according to ...
"Whether these differences in lipid effects translate into differences in the risk of cardiovascular disease has yet to be determined," lead author Dr Ronald B Goldberg (University of Miami School of ...
In a recent issue of JAMA, Lewis et al. present long-term data on the likelihood of a link between pioglitazone and the risk of bladder cancer and ten other cancers. Their findings contradict previous ...
San Diego, CA, June 11, 2005 - A new study presented today at the American Diabetes Association (ADA) 65th Annual Scientific Sessions showed that the type 2 diabetes drug ACTOS reduced C-reactive ...
* Better blood sugar lowering, weight loss with exenatide * 66 pct reach A1C target, vs 56 for Actos, 42 for Januvia By Bill Berkrot NEW YORK, June 6 (Reuters) - The high-profile experimental ...
Relatives of a Henderson man have filed a wrongful death lawsuit against the Japanese company that makes the diabetes drug Actos. The case, filed Tuesday in U.S. District Court in Las Vegas, alleges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results